Ortin Sale Purchase Of Stock vs Net Income Analysis

ORTINLAB

19.63 0.00 0.00%

Ortin Laboratories financial indicator trend analysis is much more than just breaking down Ortin Laboratories prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ortin Laboratories is a good investment. Please check the relationship between Ortin Laboratories Sale Purchase Of Stock and its Net Income accounts. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sale Purchase Of Stock vs Net Income

Sale Purchase Of Stock vs Net Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ortin Laboratories Sale Purchase Of Stock account and Net Income. At this time, the significance of the direction appears to have pay attention.

The correlation between Ortin Laboratories' Sale Purchase Of Stock and Net Income is -0.73. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Net Income in the same time period over historical financial statements of Ortin Laboratories Limited, assuming nothing else is changed. The correlation between historical values of Ortin Laboratories' Sale Purchase Of Stock and Net Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Ortin Laboratories Limited are associated (or correlated) with its Net Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income has no effect on the direction of Sale Purchase Of Stock i.e., Ortin Laboratories' Sale Purchase Of Stock and Net Income go up and down completely randomly.

Correlation Coefficient

-0.73

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Sale Purchase Of Stock

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Ortin Laboratories financial statement analysis. It represents the amount of money remaining after all of Ortin Laboratories Limited operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most indicators from Ortin Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ortin Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of November 28, 2024, Selling General Administrative is expected to decline to about 1.5 M. The current year's Tax Provision is expected to grow to about (144.5 K)

	2021	2022	2023	2024 (projected)
Interest Expense	7.9M	4.0M	4.8M	4.6M
Depreciation And Amortization	2.9M	2.5M	2.3M	2.2M

Interest Expense Depreciation And Amortization

Ortin Laboratories fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Net Receivables	Current Deferred Revenue	Short Term Debt	Short Term Investments	Other Liab
Common Stock Shares Outstanding		0.33	0.29	0.08	0.33	0.38	0.47	0.36	0.39	0.24	-0.76	0.45	-0.04	-0.77	-0.04	0.28	-0.7	-0.16	0.3	0.25	0.55	-0.09	-0.04	0.07	0.18	-0.12
Total Assets	0.33		0.88	0.39	0.98	0.91	0.84	0.88	0.7	0.9	-0.4	0.8	-0.09	-0.41	0.65	0.93	-0.74	-0.14	0.99	0.98	0.87	0.85	-0.32	0.86	-0.17	0.86
Short Long Term Debt Total	0.29	0.88		0.26	0.79	0.95	0.81	1.0	0.82	0.61	-0.43	0.83	0.05	-0.45	0.87	0.87	-0.71	-0.07	0.84	0.82	0.86	0.64	-0.2	0.96	-0.17	0.84
Other Current Liab	0.08	0.39	0.26		0.46	0.14	0.12	0.24	0.21	0.53	0.0	0.07	0.1	-0.01	0.2	0.58	-0.17	0.16	0.45	0.47	0.14	0.28	-0.96	0.25	-0.09	0.31
Total Current Liabilities	0.33	0.98	0.79	0.46		0.83	0.78	0.79	0.63	0.96	-0.33	0.71	-0.15	-0.35	0.52	0.91	-0.72	-0.16	1.0	0.99	0.82	0.88	-0.39	0.78	-0.19	0.81
Total Stockholder Equity	0.38	0.91	0.95	0.14	0.83		0.94	0.96	0.71	0.66	-0.58	0.93	0.02	-0.6	0.75	0.81	-0.71	-0.09	0.86	0.82	0.9	0.68	-0.06	0.88	-0.09	0.81
Property Plant And Equipment Net	0.47	0.84	0.81	0.12	0.78	0.94		0.84	0.47	0.64	-0.73	0.97	0.02	-0.75	0.53	0.67	-0.65	-0.09	0.79	0.72	0.83	0.59	-0.08	0.72	-0.11	0.67
Net Debt	0.36	0.88	1.0	0.24	0.79	0.96	0.84		0.81	0.6	-0.51	0.86	0.04	-0.53	0.85	0.86	-0.72	-0.09	0.83	0.8	0.87	0.61	-0.19	0.94	-0.14	0.81
Retained Earnings	0.39	0.7	0.82	0.21	0.63	0.71	0.47	0.81		0.46	-0.3	0.52	-0.15	-0.31	0.75	0.8	-0.69	-0.24	0.67	0.7	0.74	0.42	-0.09	0.74	0.1	0.57
Accounts Payable	0.24	0.9	0.61	0.53	0.96	0.66	0.64	0.6	0.46		-0.21	0.55	-0.22	-0.22	0.33	0.82	-0.6	-0.19	0.94	0.94	0.67	0.88	-0.48	0.62	-0.24	0.72
Cash	-0.76	-0.4	-0.43	0.0	-0.33	-0.58	-0.73	-0.51	-0.3	-0.21		-0.71	0.11	1.0	-0.16	-0.31	0.43	0.27	-0.33	-0.25	-0.49	0.03	-0.02	-0.22	-0.21	-0.04
Non Current Assets Total	0.45	0.8	0.83	0.07	0.71	0.93	0.97	0.86	0.52	0.55	-0.71		0.15	-0.72	0.63	0.64	-0.68	-0.03	0.74	0.65	0.84	0.52	-0.06	0.76	-0.18	0.68
Non Currrent Assets Other	-0.04	-0.09	0.05	0.1	-0.15	0.02	0.02	0.04	-0.15	-0.22	0.11	0.15		0.09	0.22	-0.13	-0.16	0.86	-0.12	-0.16	0.13	-0.14	-0.11	0.09	-0.25	0.12
Cash And Short Term Investments	-0.77	-0.41	-0.45	-0.01	-0.35	-0.6	-0.75	-0.53	-0.31	-0.22	1.0	-0.72	0.09		-0.18	-0.33	0.45	0.26	-0.35	-0.27	-0.51	0.01	-0.02	-0.23	-0.2	-0.06
Non Current Liabilities Total	-0.04	0.65	0.87	0.2	0.52	0.75	0.53	0.85	0.75	0.33	-0.16	0.63	0.22	-0.18		0.72	-0.43	0.03	0.6	0.59	0.61	0.47	-0.14	0.88	-0.16	0.79
Inventory	0.28	0.93	0.87	0.58	0.91	0.81	0.67	0.86	0.8	0.82	-0.31	0.64	-0.13	-0.33	0.72		-0.65	-0.18	0.93	0.94	0.75	0.72	-0.48	0.83	-0.09	0.8
Other Current Assets	-0.7	-0.74	-0.71	-0.17	-0.72	-0.71	-0.65	-0.72	-0.69	-0.6	0.43	-0.68	-0.16	0.45	-0.43	-0.65		-0.05	-0.72	-0.69	-0.93	-0.46	0.14	-0.62	0.25	-0.5
Other Stockholder Equity	-0.16	-0.14	-0.07	0.16	-0.16	-0.09	-0.09	-0.09	-0.24	-0.19	0.27	-0.03	0.86	0.26	0.03	-0.18	-0.05		-0.15	-0.17	0.04	-0.09	-0.14	0.01	-0.09	0.12
Total Liab	0.3	0.99	0.84	0.45	1.0	0.86	0.79	0.83	0.67	0.94	-0.33	0.74	-0.12	-0.35	0.6	0.93	-0.72	-0.15		0.99	0.84	0.88	-0.38	0.82	-0.19	0.85
Total Current Assets	0.25	0.98	0.82	0.47	0.99	0.82	0.72	0.8	0.7	0.94	-0.25	0.65	-0.16	-0.27	0.59	0.94	-0.69	-0.17	0.99		0.8	0.89	-0.38	0.81	-0.16	0.85
Common Stock	0.55	0.87	0.86	0.14	0.82	0.9	0.83	0.87	0.74	0.67	-0.49	0.84	0.13	-0.51	0.61	0.75	-0.93	0.04	0.84	0.8		0.63	-0.08	0.79	-0.16	0.71
Net Receivables	-0.09	0.85	0.64	0.28	0.88	0.68	0.59	0.61	0.42	0.88	0.03	0.52	-0.14	0.01	0.47	0.72	-0.46	-0.09	0.88	0.89	0.63		-0.23	0.73	-0.29	0.87
Current Deferred Revenue	-0.04	-0.32	-0.2	-0.96	-0.39	-0.06	-0.08	-0.19	-0.09	-0.48	-0.02	-0.06	-0.11	-0.02	-0.14	-0.48	0.14	-0.14	-0.38	-0.38	-0.08	-0.23		-0.22	0.3	-0.26
Short Term Debt	0.07	0.86	0.96	0.25	0.78	0.88	0.72	0.94	0.74	0.62	-0.22	0.76	0.09	-0.23	0.88	0.83	-0.62	0.01	0.82	0.81	0.79	0.73	-0.22		-0.3	0.93
Short Term Investments	0.18	-0.17	-0.17	-0.09	-0.19	-0.09	-0.11	-0.14	0.1	-0.24	-0.21	-0.18	-0.25	-0.2	-0.16	-0.09	0.25	-0.09	-0.19	-0.16	-0.16	-0.29	0.3	-0.3		-0.31
Other Liab	-0.12	0.86	0.84	0.31	0.81	0.81	0.67	0.81	0.57	0.72	-0.04	0.68	0.12	-0.06	0.79	0.8	-0.5	0.12	0.85	0.85	0.71	0.87	-0.26	0.93	-0.31

Click cells to compare fundamentals

Ortin Laboratories Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Ortin Stock

Balance Sheet is a snapshot of the financial position of Ortin Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Ortin Laboratories Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Ortin Laboratories and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Ortin currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ortin Sale Purchase Of Stock vs Net Income Analysis

Sale Purchase Of Stock vs Net Income

Sale Purchase Of Stock vs Net Income Correlation Analysis

Correlation Coefficient

Sale Purchase Of Stock

Net Income

Ortin Laboratories fundamental ratios Correlations

Ortin Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Other Information on Investing in Ortin Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Current Liabilities
Total Current Assets	+ 0.99	Total Liab

Current Deferred Revenue	- 0.96	Other Current Liab
Common Stock	- 0.93	Other Current Assets
Cash And Short Term Investments	- 0.77	Common Stock Shares Outstanding
Cash	- 0.76	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.75	Property Plant And Equipment Net
Other Current Assets	- 0.74	Total Assets